Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Entasis Therapeutics Holdings Inc. (ETTX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Fund
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
8 Jul 2022
Innoviva, Inc.
10% Owner
Entasis Therapeutics Holdings Inc.
(ETTX)
29,270,476
+192%
19,270,476
$2.20
$42,395,050.00
SELL
19 Oct 2021
Perros Manoussos
See Remarks, Director, Officer
Entasis Therapeutics Holdings Inc.
(ETTX)
147,526
-7%
11,974
$3.19
$38,197.06
SELL
19 Oct 2021
Mueller John Patrick
Chief Development Officer, Officer
Entasis Therapeutics Holdings Inc.
(ETTX)
45,999
-8%
4,001
$3.19
$12,763.19
SELL
19 Oct 2021
Gutch Michael
See Remarks, Officer
Entasis Therapeutics Holdings Inc.
(ETTX)
46,241
-7%
3,759
$3.19
$11,991.21
SELL
19 Oct 2021
Tommasi Ruben
Chief Scientific Officer, Officer
Entasis Therapeutics Holdings Inc.
([ETTX])
68,265
-5%
3,759
$3.19
$11,991.21
SELL
19 Oct 2021
Keiley Elizabeth M
General Counsel, Officer
Entasis Therapeutics Holdings Inc.
(ETTX)
46,241
-7%
3,759
$3.19
$11,991.21
SELL
19 Oct 2021
Altarac David
Chief Medical Officer, Officer
Entasis Therapeutics Holdings Inc.
(ETTX)
46,241
-7%
3,759
$3.19
$11,991.21
SELL
19 Oct 2021
Ronsheim Matthew
See Remarks, Officer
Entasis Therapeutics Holdings Inc.
(ETTX)
46,241
-7%
3,759
$3.19
$11,991.21
BUY
11 Jun 2021
Innoviva, Inc.
10% Owner
Entasis Therapeutics Holdings Inc.
(ETTX)
10,000,000
+168%
6,268,975
$2.00
$12,537,950.00
BUY
3 May 2021
Innoviva, Inc.
10% Owner
Entasis Therapeutics Holdings Inc.
(ETTX)
3,731,025
+100%
3,731,025
$2.00
$7,462,050.00
BUY
1 Sep 2020
Innoviva, Inc.
10% Owner
Entasis Therapeutics Holdings Inc.
(ETTX)
18,672,896
+33%
4,672,897
$2.68
$12,499,999.00
BUY
11 Jun 2020
Innoviva, Inc.
10% Owner
Entasis Therapeutics Holdings Inc.
(ETTX)
14,000,000
+958%
12,677,490
$2.50
$31,693,724.00
SELL
9 Jan 2020
Frazier Life Sciences VIII, L.P.
10% Owner
Entasis Therapeutics Holdings Inc.
(ETTX)
1,299,953
-3%
50,000
$5.00
$250,009.98
BUY
28 Sep 2018
ASTRAZENECA PLC
10% Owner
Entasis Therapeutics Holdings Inc.
(ETTX)
2,164,855
+12%
246,666
$15.00
$3,699,990.00
BUY
28 Sep 2018
Clarus Lifesciences III, L.P.
10% Owner
Entasis Therapeutics Holdings Inc.
(ETTX)
1,623,405
+38%
453,395
$15.00
$6,800,925.00
BUY
28 Sep 2018
Topper James N
Director, 10% Owner
Entasis Therapeutics Holdings Inc.
(ETTX)
1,349,953
+38%
375,887
$15.00
$5,638,305.00
BUY
28 Sep 2018
Sofinnova Venture Partners IX, L.P.
10% Owner
Entasis Therapeutics Holdings Inc.
(ETTX)
1,180,178
+40%
337,724
$15.00
$5,065,860.00
BUY
28 Sep 2018
Preston Heather
Director, 10% Owner
Entasis Therapeutics Holdings Inc.
(ETTX)
1,180,178
+40%
337,724
$15.00
$5,065,860.00
BUY
28 Sep 2018
Pivotal bioVenture Partners Fund I, L.P.
10% Owner
Entasis Therapeutics Holdings Inc.
(ETTX)
1,180,178
+40%
337,724
$15.00
$5,065,860.00
BUY
28 Sep 2018
GALAKATOS NICHOLAS
Director, 10% Owner
Entasis Therapeutics Holdings Inc.
(ETTX)
1,623,405
+38%
453,395
$15.00
$6,800,925.00
BUY
28 Sep 2018
Frazier Life Sciences VIII, L.P.
10% Owner
Entasis Therapeutics Holdings Inc.
(ETTX)
1,349,953
+38%
375,887
$15.00
$5,638,305.00
BUY
28 Sep 2018
TPG Group Holdings (SBS) Advisors, Inc.
Former 10% Owner
Entasis Therapeutics Holdings Inc.
(ETTX)
1,020,748
+34%
262,539
$15.00
$3,938,085.00
BUY
28 Sep 2018
Novo Holdings A/S
10% Owner
Entasis Therapeutics Holdings Inc.
(ETTX)
2,181,843
+99%
1,089,835
$15.00
$16,347,525.00
Home